India Says More Than Half Of Drug Maker Group Failed To File Pricing Data
This article was originally published in PharmAsia News
Fifty-five drugs face elimination from India's watchdog list of antibiotics, painkillers and other formulations set for price caps because their manufacturers failed to supply information as required.
You may also be interested in...
Two physicians experienced in agency affairs and operations, former commissioner David Kessler and former principal deputy commissioner Joshua Sharfstein, are reportedly finalists to head Biden’s FDA.
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’